当前位置：首页 > 文献互助 > 互助详情

Safety and pharmacokinetics of efinaconazole 10% solution in healthy volunteers and patients with severe onychomycosis.复制

用户g1MaVqo8u6Lw 2个月前 87 10 已关闭

DOI:复制

文献链接:复制

其他信息:

Journal of Drugs in Dermatology: JDD, 2013
europepmc.org
Objectives To characterize the systemic exposure and pharmacokinetics of efinaconazole 10% solution and assess the potential for drug-drug interaction (DDI) in human volunteers …

上一篇：Drug discovery targeting Nav1.8: Structural insights and therapeutic potential

下一篇：Genome‐Scale Modeling of CHO Cells Unravel the Critical Role of Asparagine in Cell Culture Feed Media

互助时间线

2025-05-27 11:08:46 [关闭求助]

系统关闭了求助

2025-05-22 11:08:46 [发起求助]

最新发布的求助

Evaluation and Management of the Physiologically Difficult Airway: Consensus Recommendations From Society for Airway Management 28分钟前
强直性脊柱炎诊疗规范 【中文期刊】 黄烽 朱剑 等 《中华内科杂志》 2022年61卷8期 893-900页 29分钟前
Population Pharmacokinetics and Pharmacodynamics Modeling for the Use of Recaticimab in Healthy Volunteers and Patients with Hypercholesterolemia 32分钟前
Sacroiliac joint fusion in patients with ankylosing spondylitis is associated with hip involvement 33分钟前
Recaticimab: First Approval 33分钟前
Psoriasis Risk in Patients With Atopic Dermatitis Treated With Dupilumab 45分钟前
Safety of guselkumab and ustekinumab treatment in patients with moderate-to-severe plaque psoriasis combined with latent tuberculosis or inactive hepatitis B virus infection: A retrospective multicenter observational study 47分钟前
Guselkumab for Moderate to Severe Scalp Psoriasis Across All Skin Tones 53分钟前
Adalimumab Monotherapy vs Adalimumab With Methotrexate for Psoriasis 57分钟前
A bioprintable form of chitosan hydrogel for bone tissue engineering 1小时前
Veliparib: Analytical Tools and Process Design Strategies for the Control of Mutagenic Impurities and Other Drug Substance Critical Quality Attributes 2小时前
Glycogen synthase kinase 3β (GSK-3β) inhibitors - a patent update (2019–2024) 2小时前

wispass工作室 Copyright © 蜀ICP备2024051606号-2 www.wispass.com